The Open Microbiology Journal

Prof. Adedeji obtained a doctorate (Ph.D.) in Pharmacology from the University of Ibadan, Nigeria. He holds fellowships of the American Academy of Project Management and African Technology Policy Studies Network. Currently Prof. Adedeji is also a Professor of Pharmacology in the University of Gitwe Faculty of Medicine and Health Sciences, Rwanda. He has published more than 60 scientific publications and runs a solutions platform for Health, Education and Development innovations. He is a promoter of use of Drosophila model in biomedical research in Africa through DrosAfrica, a seasoned academic manager of higher Institution of learning and research leader.

Dr. Mohamed Jawed Ahsan received B. Pharmacy (2005) and M. Pharmacy (2007) from Jamia Hamdard (University), New Delhi. He received Ph.D. (2012) from Nims University, Jaipur. Currently, he is working as Head, Department of Pharmaceutical Chemistry, Maharishi Arvind College of Pharmacy, Jaipur, India. He has a remarkable research profile in the area of Pharmaceutical and Medicinal Chemistry, and published more than 60 articles in peer reviewed Journals of International repute. Dr. Mohamed Jawed Ahsan has supervised more than 33 M. Pharmacy students. He is referee for various international journals viz; ACS Medicinal Chemistry Letters, Journal of Medicinal Chemistry, etc.

Dr. Abdul Matin received his PhD from University of London followed by a Postdoctoral Fellowship from School of Medicine, Southampton University Hospital, UK. His research interests include epidemiology and pathogenic mechanism of emerging parasitic diseases with special interest on role of Blood-brain barrier in CNS infections. He is recipient of various international and national awards, honors and grants including MRS “The Best Researcher in the UK specialty award and prize” at Royal College of Physicians, London, UK in 2007. Dr. Matin is currently Associate Professor at Majmaah University, KSA. He has published more than 32 research articles in reputed journals and is serving as an editorial board member and reviewer for various international and national reputed journals and funding agencies.

Yury Belyi obtained his doctorate degrees (PhD and Doctor of Science) in 1987 and 1999 respectively in the field of Microbiology at the Gamaleya research Institute, Moscow, Russia. He studied virulence factors of human pathogens with special interest in bacterial toxins and effectors of Type 4 secretion system. Currently Dr. Belyi holds a position of a Head of the Department of Bacterial infections at the Gamaleya Research Center for Epidemiology and Microbiology in Moscow, Russia. He has prepared more than 50 scientific papers and has written a monograph “Intracellular parasitism of microorganisms” published in 1996 by Landes Bioscience, Austin, TX.

Dr. Andrea Cara, Ph.D., is a Researcher at Istituto Superiore di Sanità, Rome, Italy, and holds a Research Scholar position in the Department of Medicine at Duke University, Durham, NC, USA. During his career, he spent 7 years at the National Institute of Health in Bethesda, MD, USA, and 3 years at the Mount Sinai School of Medicine, New York City, NY, USA. Dr. Cara, as an author/co-author, has published more than 75 articles in various journals, having a significant number of total citations, i.e. over 3,330.

Professor Dr. Mohammad Hadi Dehghani (PhD) is a Full Professor at the Tehran University of Medical Sciences (TUMS), School of Public Health, Department of Environmental Health Engineering, Tehran, IRAN. His scientific research interests include the Environmental Health Science, Microbiology of Water and Wastewater. He is the author of various research studies published at national and international journals, conference proceedings and Head of several research project at the TUMS. He has authored 8 books and more than 170 full papers published in peer- reviewed journals. He is an editorial board member and reviewer in many internal and international journals and is member of several international science committees around the world. He has supervisor and advisor PhD and MSc theses at the TUMS. He is currently also member of the Iranian Association of Environmental Health (IAEH) and member of the Institute for Environmental Research (IER) at the TUMS.

Dr. Filomena Fiorito is currently a Post-Doc Fellow, at Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici (Naples), Italy. She did M.Sc. in Pharmaceutical chemistry and Pharmacy from University of Rome “La Sapienza”, Italy in 1995 and 1996. She obtained her Ph.D. in Environmental Biology, Pathology and Hygiene in Veterinary Medicine from University of Naples “Federico II”, Italy in 2005. Dr. Fiorito has numerous awards/honors and internationally recognized scientific publications to her credit.

Yinduo Ji obtained his Ph.D. from the Chinese Academy of Preventive Medicine (current Chinese Center for Disease Control and Prevention) in Beijing. He did his postdoctoral training in the Department of Microbiology at the University of Minnesota. Currently Dr. Ji is a Professor of Microbiology in the Department of Veterinary and Biomedical Sciences at the University of Minnesota. He has more than 70 scientific publications and serves as Editor-in-Chief, Associate Editor, or Editorial Board Member for multiple peer-reviewed journals. His research focuses on the molecular and cellular pathogenesis of S. aureus, functional genomics, and antibacterial drug discovery.

Dr. Martinez got PhD in 1885. She has presently been serving as a Professor and Researcher at the Genomic Science Center, National University of Mexico. She has been recognized with many awards and honors such as Prize of Science from the Mexican Academy of Sciences in 1996, Award to Young Scientists from the National University of Mexico in 1996, Award from the National Research Council as “The Best Student of Mexico” and Woman of the Year for Mexico by the American Biogeographical Institute in 2008. She has contributed more than 300 publications, having citations around 10,367.

Dr. Carla Palma obtained a doctorate (Ph.D.) in Medical Microbiology and immunology from the University of “Tor Vergata” Rome, Italy. Currently Dr. Palma is a Researcher in the Department of Infectious Diseases of Istituto Superiore di Sanità (Italian National Institute of Health), Rome, Italy. She has published more than 50 scientific publications.

Dr. Asem Shehabi is a Professor of Medical Microbiology and Consultant in Diagnostic Microbiology, Faculty of Medicine, University of Jordan, Amman, Jordan. Dr. Shehabi graduated from the University of Kiel, Germany in 1972 with a Doctorate degree in Medical Sciences/ Medical Microbiology. Dr. Shehabi has published 97 research papers in peer-reviewed journals up till now, 2 Microbiology Books in Arabic, more than 300 articles and studies in both Arabic and English; covering all aspects of medical microbiology and human infectious diseases especially antimicrobial resistance. He is currently the Editor-in-Chief of The International Arabic Journal of Antimicrobial Agents, iMedPub.org.

Morovat Taherikalani is a Professor in the Department of Medical Microbiology and Razi Herbal Medicines Research Center at Lorestan University of Medical Sciences, where he has been since 2015. From 2008 to 2018, he served as Department Chair of Medical Microbiology at Ilam University of Medical Sciences. He received a B.S. in Laboratory Sciences in 2001 form Tabriz University, and an M.S. and PhD in Medical Microbiology from the Tehran University of Medical Sciences in 2004 and 2008 respectively.

Professor Gilda Tachedjian received her Ph.D. degree in Microbiology in 1997 from Monash University, Victoria, Australia. In 2002, Prof. Tachedjian was recruited to Burnet Institute, where she performed key roles of Head, Molecular Interactions Group (2003-2010) and Head, Retroviral Biology and Antivirals Laboratory (2011). Now, since 2017, she is the Head of Life Sciences at this same institute. Prof. Tachedjian’s current research interests include identification of novel RT inhibitors, and development of topical microbicides to prevent the transmission of HIV and other sexually transmitted infections. She has been involved in the publication of over 75 articles in various international journals.

Dr. David Gutnick obtained his Ph.D. degree (1967) in Microbiology from University of Southern California, Los Angeles, CA, specializing in oxidative phosphorylation in Mycobacterium phlei. Dr. Gutnick is currently affiliated with Tel-Aviv University (Department of Biotechnology Life Sciences), Israel. In addition, he is Chairman of Technology Accreditation Professional Sub Committee of the Council for Higher Education, and a member of the Committee on Microbiology of the Israel Academy of Sciences. His current research interests include petroleum microbiology, biosurfactants and biopolymers, and microbial complex pattern formation. Dr. Gutnick is the author/co-author of over 130 papers, patents, reviews and book chapters.

Dr. A. Mengoni has obtained PhD and currently working at ENEA-Bologna, Italy. Mengoni does research in Nuclear Physics. Mengoni’s skills and expertise are in Data Analysis, Energy, Astronomy & Astrophysics, Measurement, Radioactivity, Detectors, Experimental Nuclear Physics, Nuclear Physics, Nuclear Structure, Theoretical Nuclear Physics, Nuclear Reactions, Nuclear Astrophysics and Nuclear Chemistry. Mengoni has contributed more than 387 publications, having citations around 3539.

Dr. A. Segura has obtained PhD and currently working at the Experimental Station of Zaidín, Spanish National Research Council. Ana’s research interests include Immunology and Microbiology Biochemistry, Genetics and Molecular Biology Agricultural and Biological Sciences Chemical Engineering Environmental Science Medicine Pharmacology, Toxicology and Pharmaceutics Engineering. Ana has contributed more than 74 publications, having citations around 3026.

Dr. Farhat Afrin received Ph.D. from Indian Institute of Chemical Biology, Kolkata, India. She served Department of Biotechnology, Hamdard University, New Delhi, India for 16 years. She also worked at National Institutes of Health, Bethesda, MD, USA and Centre for Immunology and Infection, University of York, UK. She is a recipient of several honors including American Association of Immunologists Young Faculty Travel Grant, Commonwealth Academic Staff fellowship. Her research interest is parasite immunology with emphasis on Leishmania immunotherapeutics. She has published over 55 papers in Journals of International repute and is an Academic Editor, Editorial Board member and reviewer of several Journals.

Dr. A. Cid Arregui obtained his doctorate in Medicine (MD) and Molecular Biology (PhD) at the Autonomous University of Madrid and the European Molecular Biology Laboratory in Heidelberg. Dr. Arregui has more than 20 years of research experience in the field of cancer associated with human Papillomaviruses. Dr. Arregui is currently a group leader in the Tumor Immunology department of the German Cancer Research Center in Heidelberg, Germany.

Dr. Andrea Battistoni is a stable member of the Department of Biology, University of Rome Tor Vergata, Rome, Italy, since 1993.Dr. Battistoni received his Ph.D. degree in Cellular and Molecular Biology in 1991 from the University of Rome Tor Vergata. He is a co-author of over 100 papers published in international journals indexed by Pub-Med. He is a member of the Editorial Board of various journals, and also is a member of the American Society for Microbiology, the International Biometals Society, the Italian Biochemical Society and the Italian Society for the Study of Cystic Fibrosis.

Alfonso Martín Cabello-Vílchez was born in Lima on 07 July 1975. Dr. Alfonso Martín Cabello-Vílchez received his Medical Technologist education in the Universidad Peruana Cayetano Heredia (UPCH), Instituto de Medicina Topical Alexander von Humboldt (IMT-AvH), Lima-Peru in 2003.He is currently Professor of Medical Parasitology and He has 15 publications in Journal of Microbiology and Parasitology since 2010. He is currently head of the Lab of protists and human pathogenic endosymbionts of IMT-AvH. My research focuses on free-living amoebae and endosymbiotic processes that cause disease in humans. His group is currently interested in developing diagnostic methods for Leprosy and Buruli in South America.

Dr. Katerina Chlichlia is Associate Professor of Molecular Immunobiology at the Department of Molecular Biology & Genetics, Democritus University of Thrace in Alexandroupolis, Greece. She received her PhD from the German Cancer Research Center and Faculty of Pharmacy in Heidelberg (1994) and continued for Post-Doctoral studies in Germany. She has long experience in the fields of molecular biology, microbiology and immunology. She received fellowships from DAAD, UICC and DFG. She has published more than 40 articles in peer-reviewed journals, has served as an evaluator in many national and international grant applications and as a reviewer in scientific journals.

Alexander V. Dmitriev obtained PhD degree (1997) and DrSc degree (2004) in Microbiology and Biochemistry at the Institute of Experimental Medicine, Saint-Petersburg, Russia. He is currently Deputy Director of the Institute of Experimental Medicine and Professor at Saint-Petersburg State University and Saint-Petersburg State Technological Institute. He was working in different laboratories in USA, Slovakia, China, Vietnam and Portugal. He has published more than 180 publications. He was awarded by numerous grants and awards including international.

Dr. Giongo is a microbial ecologist with Ph.D. in Genetics and Molecular Biology (Brazil, 2007) and Post doctorate in Microbial Ecology (University of Florida, USA, 2008-2011). She is Visiting Professor of the Environmental Engineering Graduate Program at FURB (Brazil). Her research projects include the knowledge of the microbial communities associated with different environmental samples and the influence on the atmosphere, lithosphere, and hydrosphere. She has published more than 40 scientific articles in international journals.

Dr. Benfang Lei obtained a doctorate (Ph.D.) in Biochemistry from the University of Houston, Houston, Texas. Currently Dr. Lei is an Associate Professor at Department of Microbiology and Immunology, Montana State University, Bozeman, Montana. He has published more than 70 scientific publications. He has been on the Editorial Board of this journal since 2007.

João R. Mesquita (Mesquita JR) obtained his DVM in 2006 (University of Trás-os-Montes and Alto Douro) and his PhD in 2012 (University of Porto). He has been teaching at the Agrarian Superior School of Viseu (ESAV), Polytechnic Institute of Viseu (IPV) for the past 10 years, mainly on the topics of Infectious Diseases. He currently holds the position of Adjunct Professor and has published more than 40 articles in virology.

Dr. Rathinam Raja pursued his Ph.D., in microalgae at University of Madras during 2004. He did his Post-Doctoral Fellowships at Taiwan, South Korea, IIT Madras and worked as a Lead Scientist at Aquatic Energy LLC, Louisiana, USA. Currently, working as an Assistant Researcher at University of the Algarve, Portugal. He has 21 international peer reviewed publications, 10 book chapters, membership in several scientific international bodies and serving as an Editor in Chief, Associate Editor, Editorial Board member in many journals. Being a Scientist, he has presented his research articles in several conferences/symposium at Belgium, Denmark, Dubai, France, Germany, Hungary, Malaysia, Morocco, New Zealand, Portugal, Singapore, Slovakia, Spain, South Korea, Taiwan, Thailand, The Netherlands (Holland) and USA.

Dr. Ashraf Tabll did B.Sc. from faculty of science (Damietta) Mansoura University and M.Sc. in chemistry from faculty of science, Menofia University in 1990 and 1997 respectively. Later in 2001, he did PhD in Biochemistry from faculty of Science, Cairo University. Dr. Tabll has a good experience in establishment of cell lines producing of mouse monoclonal antibodies for immunodiagnosis by hybridoma technology and establishment of human cell lines producing of human monoclonal antibodies for immunotherapy by EBV immortalization of B lymphocytes. Dr. Tabll published more than 50 international articles.

Prof. Tong obtained his medical degrees (M.B.,B.S., MD) from the University of Hong Kong and the University of the State of New York. He is American Board of Pathology-certified and fellowship-trained at Memorial Sloan Kettering Cancer Center. He is an Adjunct Professor of Pathology at City of Hope Comprehensive Cancer Center and a consultant at University of Hong Kong-Shenzhen Hospital. He has published dozens of peer-reviewed scientific articles, owns 4 U.S. patents and is a co-inventor in a pending U.S. patent application. He is on the editorial board of multiple journals, including this journal, published by Bentham Science Publishers.

As molecular biologist I initiated my research career in the field of HTLV infections, and epidemiologic research on HIV. Once obtained my PhD degree in 1993, I moved to the Food and Drug Administration, Maryland, USA, with a post-doctoral position working on molecular epidemiology of HTLV and HIV. In 2000, I returned to Spain to join the Immunovirology Laboratory at Virgen del Rocío Hospital, Seville, and focused on immune recovery of HIV-1-infected patients. I then moved to Ramon y Cajal Hospital at Madrid to follow my research on HIV-1 immunopathology and continuing the research on HTLV-1/2 infections.

Dr. Giovanni Bonfiglio obtained PhD and presently serving at the University of Catania, Department of Microbiological Sciences Catania, Italy. Giovannis’ research interests include Medicine Immunology and Microbiology Pharmacology, Toxicology and Pharmaceutics Biochemistry, Genetics and Molecular Biology Decision Sciences Mathematics Social Sciences. Giovanni has contributed more than 58 publications, having citations around 763.

Dr. David Harrich obtained his Ph.D. degree in Experimental Pathology from University of California, Los Angeles, CA, USA, and undertook postdoctoral training at University of Texas Southwestern Medical Centre, Dallas, TX, USA. Dr. Harrich is Group Leader of HIV and Molecular Virology at QIMR Berghofer Medical Research Institute, Brisbane, Australia, where he is a Senior Research Fellow. He has published over 70 papers, most of them on HIV-1 molecular biology and virus replication.

Dr. Alexander Plyusnin is currently affiliated with University of Helsinki (Department of Virology), Helsinki, Finland. His skills and expertise mainly lie in the subject areas of Cell Biology, Molecular Biology, Cancer Research, Genetics, Biotechnology, Immunology, Microbiology, Biochemistry, Pharmacology, Immunochemistry, etc. Dr. Plyusnin, as an author/co-author, has published more than 150 articles in various journals, having a significant number of total citations, i.e. over 5,765.

I received master degree in Clinical Microbiology from Institute of Medicine (IOM, Tribhuvan University), Nepal. I worked as assistant professor in the department of Clinical Microbiology, Chitwan Medical College, Nepal. I focused my interest on antibacterial resistance and within five years published more than 30 research papers in high impact international journals. I also involved in making of guidelines regarding antimicrobial treatment. Recently I was awarded for pursuing PhD in infectious diseases of gastro-intestinal tract by government of Japanese. Currently, I am also active member of several international societies of infectious diseases such as ASM, ESCMID, ISID, IDRN and GAIS.

Prof. Reza Ranjbar is a microbiologist. He completed masters in Medical Microbiology from Shaheed Beheshti University of Medical Sciences, Tehran, Iran and obtained PhD in Medical Bacteriology from Tehran University of Medical Sciences, Tehran, Iran. At present he is full professor, and chairman of Molecular Biology Research Center, BMSU, Tehran, Iran. His fields of expertise’s are: Molecular epidemiology of bacteria, Molecular detection of bacteria, and Molecular epidemiology of antimicrobial resistance. To date, he has published more than 315 scientific papers.

Reza Taherkhani is an assistant professor at Medical Faculty of Bushehr University of Medical Sciences. In addition to his teaching position, Taherkhani served as a researcher at Persian Gulf Tropical Medicine Research Center. Reza Taherkhani’s main area of research is DNA vaccine development against hepatitis E virus. Reza Taherkhani was born and raised in Tehran, capital of Iran. He obtained his Bachelor of Laboratory Science in Urmia University in 2003, M.Sc. in Medical Virology in 2006 from Razi Vaccine and Serum Research Institute, and Ph.D. in Medical Virology in 2014 from Ahvaz Jondishpoor University of Medical Sciences.

Prof. Abdulaziz Zorgani obtained DipBact diploma and MSc degree from the Department of Pathological Sciences at the University of Manchester. He received his PhD degree from the Department of Medical Microbiology at the University of Edinburgh. He has extensive teaching experience in the Faculty of Medicine at the University of Tripoli. Most of it focused on teaching medical microbiology and practicing clinical microbiology. During this post, he has published 66 scientific articles; the majority are related to antibiotic resistance and health care associated infection. His interests include: antibiotic resistance, healthcare associated infection, and sterilization and disinfection.

Dr. José Mengel earned his M.D. and Ph.D. from the Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil. Following a postdoc at the University of Alabama at Birmingham with Prof. John F. Kearney. He is a senior researcher at the Laboratory of Clinical Immunology, Oswaldo Cruz Institute (IOC/FIOCRUZ), Brazil and Professor of Immunology at the Faculty of Medicine of Petrópolis, Brazil. His research interests are related to the immunology of host/parasite relationship with an emphasis on immune regulation.

Marina Stukova, MD, PhD is a head of the laboratory of vectored vaccines in Saint Petersburg Research Institute of Influenza, Russian Ministry of Health. Dr. Stukova is focusing her research, now, in developing and studying influenza vectored vaccines against bacterial and viral diseases including TB and RSV with different routes of vaccine delivery. Dr. Stukova coordinated clinical trials of new influenza vaccines including the LAIV Vaccine Projects, funded by PATH Vaccine Solutions and WHO aimed at establishing a collection of pre-pandemic influenza vaccines which could be used as a basis for vaccine manufacturing in a pandemic situation.